Head-to-head · WeighScore
PlushCare vs TrueMe
By GLP-1 ScorecardUpdated
Score comparison
PlushCare has the higher recorded score — 74.5/100 to 67.6/100.
PlushCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlushCare suits shoppers who want a physician video visit and pharmacy choice, but membership, appointments, medication and labs are separate costs.
Before you choose
PlushCare does not publish a semaglutide price, so its PlushCare review sets out what it does disclose, while the TrueMe review explains the conditions attached to TrueMe's figure. The semaglutide cost page compares published rates across the field. Ask PlushCare for a written total before treating either one as the cheaper choice.
If neither one fits, 9amHealth vs PlushCare and RxSpan MD vs TrueMe compare each of them with another graded program, and the list of alternatives to PlushCare ranks the programs closest to PlushCare on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | PlushCare | TrueMe |
|---|---|---|
| WeighScore | 74.5/100 | 67.6/100 |
| Grade | C | C |
| Site position | #67 | #176 |
| Semaglutide | Varies (branded prescription; visits and advertised membership separate) | Compounded "GLP-1" (drug not named) $139 for one month, $89 a month on a 3-month plan |
| Tirzepatide | Varies (branded prescription; visits and advertised membership separate) | Compounded "GLP-1/GIP" (drug not named) $149 for one month, $99 a month on a 3-month plan |
| Coverage | All 50 states | 6 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #67 · C
Strengths
- Available in all 50 states
- Video appointments with primary care physicians
- Prescriptions can be sent to a pharmacy you choose
- Visit insurance and medication prior-authorization assistance offered; coverage depends on the plan
What to consider
- Advertised membership is $19.99 monthly after the first free month or $149 annually prepaid; visits, drugs and labs are separate
- Terms say membership is optional for medical services, while general FAQ implies active membership; confirm the nonmember booking route
- Cancel at least one calendar day before membership renewal; a visit can be nonrefundable after clinical assessment even without a prescription
Strengths
- One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
- Same price at every dose, so the cost does not climb as a provider titrates the dose upward
- Full pricing is published up front — no intake form is required before you can see what you will pay
- Names its telehealth platform (Telegra) and physician network (Strive), and the returns address names CarePoint Infusion Pharmacy in Stafford, Texas
What to consider
- Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
- Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
- You pay before completing the medical intake, and approval is not guaranteed at the moment you are charged
- The 3-month rates ($119 and $139/mo) are a single upfront charge of $357 or $417, not a lower monthly plan
- A Featured In strip shows CNN, Fox News, Forbes, New York Times and NPR logos with no linked coverage
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.